AVITA Medical, Inc.
RCEL
$9.91
-$0.15-1.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.75% | 23.44% | -0.28% | 18.62% | 35.56% |
| Total Depreciation and Amortization | 9.60% | 20.35% | 58.19% | 85.16% | 170.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 154.53% | -23.13% | -62.34% | 1.98% | -62.28% |
| Change in Net Operating Assets | 167.08% | -1,025.73% | 640.88% | -59.73% | -3,407.84% |
| Cash from Operations | 65.82% | 2.30% | 32.71% | 27.65% | 19.96% |
| Capital Expenditure | 79.39% | 91.40% | 141.81% | 75.16% | 80.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.99% | -81.25% | -116.24% | -139.51% | -50.01% |
| Cash from Investing | -44.57% | -81.04% | -99.55% | -172.23% | -43.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.82% | -- | -75.71% | 1,372.10% | -34.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.82% | 1,579.61% | -75.71% | 1,267.03% | -34.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.27% | -335.85% | -12.86% | 170.09% | -629.74% |